NRX Pharmaceuticals, Inc.

Q2 2026 13F Holders

Symbol
NRXP
CUSIP
629444209
Type
Equity
Class
COM NEW
Num filings
52
Total reported value, excl. options
$47.6 M
Manager Report Date Value ($000) Shares Option Type